Forte Biosciences (FBRX) Cash & Equivalents (2016 - 2020)
Historic Cash & Equivalents for Forte Biosciences (FBRX) over the last 5 years, with Q3 2020 value amounting to $20.2 million.
- Forte Biosciences' Cash & Equivalents fell 2103.21% to $20.2 million in Q3 2020 from the same period last year, while for Sep 2020 it was $20.2 million, marking a year-over-year decrease of 2103.21%. This contributed to the annual value of $6.9 million for FY2019, which is 8299.81% down from last year.
- Latest data reveals that Forte Biosciences reported Cash & Equivalents of $20.2 million as of Q3 2020, which was down 2103.21% from $27.7 million recorded in Q2 2020.
- In the past 5 years, Forte Biosciences' Cash & Equivalents registered a high of $76.1 million during Q2 2017, and its lowest value of $4.1 million during Q3 2016.
- In the last 5 years, Forte Biosciences' Cash & Equivalents had a median value of $20.2 million in 2020 and averaged $24.5 million.
- As far as peak fluctuations go, Forte Biosciences' Cash & Equivalents soared by 173077.3% in 2017, and later plummeted by 8299.81% in 2019.
- Quarter analysis of 5 years shows Forte Biosciences' Cash & Equivalents stood at $5.5 million in 2016, then soared by 552.14% to $35.9 million in 2017, then grew by 13.58% to $40.8 million in 2018, then crashed by 83.0% to $6.9 million in 2019, then surged by 191.11% to $20.2 million in 2020.
- Its Cash & Equivalents stands at $20.2 million for Q3 2020, versus $27.7 million for Q2 2020 and $14.2 million for Q1 2020.